Internal hearing damage induced by radiotherapy (RT) can lead to sensorineural hearing loss (hypoacusia) due tumor’s proximity with the auditory apparatus. Furthermore, the concurrent use of RT with chemotherapy (cisplatin) is known to increase toxicity. To quantify the radiation dose delivered to the (ipsilateral and contralateral) cochlea in head and neck cancer patients with and without hypoacusia.
